{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:12:40Z","timestamp":1785265960466,"version":"3.55.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Centre for Clinical Research, Uppsala University"},{"name":"Swedish Breast Cancer Association"},{"DOI":"10.13039\/100018650","name":"Percy Falk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Breast cancer patients undergoing mastectomy are not well represented in studies evaluating the omission of completion axillary lymph node dissection (cALND) due to sentinel lymph node (SLN) metastases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The prospective multicentre SENOMIC cohort trial included patients with breast cancer and SLN micrometastases between October 2013 and December 2022. Completion ALND was omitted and nodal radiotherapy discouraged. Patients undergoing mastectomy were selected for the present analysis. The primary endpoint was event-free survival. Secondary endpoints were the isolated axillary recurrence rate (ARR) and cancer-specific and overall survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the SENOMIC trial, 455 of 882 included patients underwent mastectomy, 407 of whom did not receive nodal radiotherapy. The median follow-up time was 53 (range 5\u2013109) months. The estimated 5-year event-free, cancer-specific, and overall survival were 86.8%, 97.0% and 91.6%, respectively. Isolated axillary recurrence was found in 14 patients (3.1%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Event-free survival after omission of cALND in breast cancer patients with SLN micrometastases undergoing mastectomy was excellent, despite a higher ARR than previously reported. Long-term follow-up is important to validate the safety of this approach, but omission of cALND should be regarded as routine care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjs\/znaf111","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:58:03Z","timestamp":1749211083000},"source":"Crossref","is-referenced-by-count":7,"title":["Omitting completion axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases undergoing mastectomy: results from the prospective SENOMIC trial"],"prefix":"10.1093","volume":"112","author":[{"given":"Yvette","family":"Andersson","sequence":"first","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University , Uppsala ,","place":["Sweden"]},{"name":"Centre for Clinical Research V\u00e4stmanland, Uppsala University , V\u00e4ster\u00e5s ,","place":["Sweden"]},{"name":"Department of Surgery, V\u00e4stmanland Hospital V\u00e4ster\u00e5s , V\u00e4ster\u00e5s ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Bergkvist","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University , Uppsala ,","place":["Sweden"]},{"name":"Centre for Clinical Research V\u00e4stmanland, Uppsala University , V\u00e4ster\u00e5s ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ryd\u00e9n","sequence":"additional","affiliation":[{"name":"Division of Oncology and Surgery, Faculty of Medicine, Department of Clinical Sciences, Lund University , Lund ,","place":["Sweden"]},{"name":"Department of Gastroenterology and Surgery, Sk\u00e5ne University Hospital , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuat","family":"Celebioglu","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Education, S\u00f6dersjukhuset, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Karin","family":"Falck","sequence":"additional","affiliation":[{"name":"Division of Oncology and Surgery, Faculty of Medicine, Department of Clinical Sciences, Lund University , Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Norenstedt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Capio St G\u00f6ran\u2019s Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecka","family":"Ruderfors Malterling","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ryhov County Hospital , J\u00f6nk\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9441-4420","authenticated-orcid":false,"given":"Eva","family":"Vikhe Patil","sequence":"additional","affiliation":[{"name":"Department of Surgery, BKV University Hospital , Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Frisell","sequence":"additional","affiliation":[{"name":"Breast Centre Karolinska, Karolinska Comprehensive Cancer Centre, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9518-0902","authenticated-orcid":false,"given":"Jana","family":"de Boniface","sequence":"additional","affiliation":[{"name":"Department of Surgery, Capio St G\u00f6ran\u2019s Hospital , Stockholm ,","place":["Sweden"]},{"name":"Breast Centre Karolinska, Karolinska Comprehensive Cancer Centre, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"2025060607575770700_znaf111-B1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","article-title":"Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases","volume":"63","author":"Carter","year":"1989","journal-title":"Cancer"},{"key":"2025060607575770700_znaf111-B2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3","article-title":"Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update","volume":"52","author":"Fisher","year":"1983","journal-title":"Cancer"},{"key":"2025060607575770700_znaf111-B3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10549-010-1210-7","article-title":"Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review","volume":"125","author":"Pepels","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"2025060607575770700_znaf111-B4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"2025060607575770700_znaf111-B5","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J Clin Oncol"},{"key":"2025060607575770700_znaf111-B6","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s00268-023-07072-8","article-title":"Can axillary lymph node dissection be omitted in breast cancer patients with metastatic sentinel lymph nodes undergoing mastectomy? A systematic review and meta-analysis of real-world evidence","volume":"47","author":"Chen","year":"2023","journal-title":"World J Surg"},{"key":"2025060607575770700_znaf111-B7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"N Engl J Med"},{"key":"2025060607575770700_znaf111-B8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-022-06727-9","article-title":"Axilla lymph node dissection can be safely omitted in patients with 1\u20132 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis","volume":"196","author":"Gao","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"2025060607575770700_znaf111-B9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the Optimal Treatment Of the Axilla \u2013 Surgery or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"Savolt","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"2025060607575770700_znaf111-B10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/bjs\/znad215","article-title":"Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment","volume":"110","author":"Tinterri","year":"2023","journal-title":"Br J Surg"},{"key":"2025060607575770700_znaf111-B11","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"key":"2025060607575770700_znaf111-B12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10549-021-06341-1","article-title":"Outcomes of stage I and II breast cancer with nodal micrometastases treated with mastectomy without axillary therapy","volume":"189","author":"Lim","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"2025060607575770700_znaf111-B13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/bjs\/znab141","article-title":"Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial","volume":"108","author":"Andersson","year":"2021","journal-title":"Br J Surg"},{"key":"2025060607575770700_znaf111-B14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3322\/caac.21393","article-title":"Breast cancer\u2014major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2025060607575770700_znaf111-B15","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1200\/JCO.2009.24.5001","article-title":"Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes","volume":"28","author":"Andersson","year":"2010","journal-title":"J Clin Oncol"},{"key":"2025060607575770700_znaf111-B16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"2025060607575770700_znaf111-B17","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3390\/cancers16152666","article-title":"Omission of completion axillary lymph node dissection for patients with breast cancer treated by upfront mastectomy and sentinel node isolated tumor cells or micrometastases","volume":"16","author":"Houvenaeghel","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2025060607575770700_znaf111-B18","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1245\/s10434-024-15049-7","article-title":"Oncological safety of skipping axillary lymph node dissection in patients with clinical N0, sentinel node-positive breast cancer undergoing total mastectomy","volume":"31","author":"Chun","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2025060607575770700_znaf111-B19","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1245\/s10434-012-2490-4","article-title":"Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literature","volume":"19","author":"Francissen","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"2025060607575770700_znaf111-B20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12957-023-03082-x","article-title":"Prognosis and local treatment strategies of breast cancer patients with different numbers of micrometastatic lymph nodes","volume":"21","author":"Luo","year":"2023","journal-title":"World J Surg Oncol"},{"key":"2025060607575770700_znaf111-B21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"key":"2025060607575770700_znaf111-B22","doi-asserted-by":"crossref","first-page":"znae077","DOI":"10.1093\/bjs\/znae077","article-title":"De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1\u20132 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07)","volume":"111","author":"de Wild","year":"2024","journal-title":"Br J Surg"},{"key":"2025060607575770700_znaf111-B23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1245\/s10434-016-5605-5","article-title":"Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy","volume":"24","author":"FitzSullivan","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"2025060607575770700_znaf111-B24","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1245\/s10434-023-13942-1","article-title":"Extremely low incidence of local-regional recurrences observed among T1-2 N1 (1 or 2 positive SLNs) breast cancer patients receiving upfront mastectomy without completion axillary node dissection","volume":"30","author":"Zaveri","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2025060607575770700_znaf111-B25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.ejso.2014.07.041","article-title":"Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease","volume":"40","author":"Galimberti","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"2025060607575770700_znaf111-B26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10434-004-1166-0","article-title":"Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance","volume":"12","author":"Smidt","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"2025060607575770700_znaf111-B27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ejso.2012.04.016","article-title":"Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients","volume":"38","author":"van Wely","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"2025060607575770700_znaf111-B28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/SLA.0b013e31823dc616","article-title":"Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells","volume":"255","author":"Pepels","year":"2012","journal-title":"Ann Surg"},{"key":"2025060607575770700_znaf111-B29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1046\/j.1365-2168.2002.02117.x","article-title":"Consequences of axillary recurrence after conservative breast surgery","volume":"89","author":"Fredriksson","year":"2002","journal-title":"Br J Surg"},{"key":"2025060607575770700_znaf111-B30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-013-2608-9","article-title":"Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival","volume":"140","author":"Bulte","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2025060607575770700_znaf111-B31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.critrevonc.2018.06.013","article-title":"Critical review of axillary recurrence in early breast cancer","volume":"129","author":"Castaneda","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025060607575770700_znaf111-B32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2168.2001.01637.x","article-title":"Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer","volume":"88","author":"de Boer","year":"2001","journal-title":"Br J Surg"},{"key":"2025060607575770700_znaf111-B33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archsurg.141.9.867","article-title":"Management and outcomes of isolated axillary node recurrence in breast cancer","volume":"141","author":"Konkin","year":"2006","journal-title":"Arch Surg"},{"key":"2025060607575770700_znaf111-B34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0002-9610(00)00456-6","article-title":"Presentation, management and outcome of axillary recurrence from breast cancer","volume":"180","author":"Newman","year":"2000","journal-title":"Am J Surg"},{"key":"2025060607575770700_znaf111-B35","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1245\/ASO.2003.01.017","article-title":"Outcomes after localized axillary node recurrence in breast cancer","volume":"10","author":"Wright","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"2025060607575770700_znaf111-B36","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.breast.2013.07.054","article-title":"Incidental radiation to axilla in early breast cancer treated with intensity modulated tangents and comparison with conventional and 3D conformal tangents","volume":"22","author":"Kataria","year":"2013","journal-title":"Breast"},{"key":"2025060607575770700_znaf111-B37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/bjs.7360","article-title":"Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy","volume":"98","author":"van Wely","year":"2011","journal-title":"Br J Surg"},{"key":"2025060607575770700_znaf111-B38","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/cancers16061198","article-title":"Does breast surgery type Alter incidental axillary irradiation? A dosimetric analysis of the \u201csentinel envahi et randomisation du curage\u201d SERC trial","volume":"16","author":"Nicolas","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2025060607575770700_znaf111-B39","first-page":"100770","article-title":"Postmastectomy radiation therapy in breast cancer patients with micrometastatic disease in sentinel node dissection: a cohort study and meta-analysis","volume":"46","author":"Jafer","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"2025060607575770700_znaf111-B40","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/02841850701305440","article-title":"Lymph drainage studied by lymphoscintigraphy in the arms after sentinel node biopsy compared with axillary lymph node dissection following conservative breast cancer surgery","volume":"48","author":"Celebioglu","year":"2007","journal-title":"Acta Radiol"},{"key":"2025060607575770700_znaf111-B41","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1200\/JCO.2010.28.2491","article-title":"Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: national surgical adjuvant breast and bowel project phase III protocol B-32","volume":"28","author":"Land","year":"2010","journal-title":"J Clin Oncol"},{"key":"2025060607575770700_znaf111-B42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10549-019-05328-3","article-title":"Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer","volume":"177","author":"Andersson","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"2025060607575770700_znaf111-B43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01807163","article-title":"Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy","volume":"41","author":"Demicheli","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"2025060607575770700_znaf111-B44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jso.2930430312","article-title":"Dormancy and breast cancer","volume":"43","author":"Meltzer","year":"1990","journal-title":"J Surg Oncol"},{"key":"2025060607575770700_znaf111-B45","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N Engl J Med"},{"key":"2025060607575770700_znaf111-B46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-018-4820-0","article-title":"Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes","volume":"171","author":"Andersson","year":"2018","journal-title":"Breast Cancer Res Treat"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/112\/6\/znaf111\/63444915\/znaf111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/112\/6\/znaf111\/63444915\/znaf111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:58:10Z","timestamp":1749211090000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/doi\/10.1093\/bjs\/znaf111\/8157678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,6]]},"published-print":{"date-parts":[[2025,5,31]]}},"URL":"https:\/\/doi.org\/10.1093\/bjs\/znaf111","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,5,31]]},"article-number":"znaf111"}}